Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 2:6:7.
doi: 10.3389/fneur.2015.00007. eCollection 2015.

Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis

Farnaz Amoozegar  1 , Paul E Ronksley  2 , Reg Sauve  3 , Bijoy K Menon  4
Affiliations
Review

Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis

Farnaz Amoozegar et al. Front Neurol. .

Abstract

Objectives: Use of oral contraceptive pills (OCP) increases the risk of cerebral venous sinus thrombosis (CVST). Whether this risk varies by type, duration, and other forms of hormonal contraceptives is largely unknown. This systematic review and meta-analysis update the current state of knowledge.

Methods: We performed a search to identify all published studies on the association between hormonal contraceptive use and risk of CVST in women aged 15-50 years.

Results: Of 861 studies reviewed, 11 were included. The pooled odds of developing CVST in women aged 15-50 years taking OCPs was 7.59 times higher compared to women not taking OCPs (OR = 7.59, 95% CI 3.82-15.09). Data are insufficient to make conclusions about duration of use and other forms of hormonal contraceptives.

Conclusion: Oral contraceptive pills use increases the risk of developing CVST in women of reproductive age. Future studies are required to determine if duration and type of hormonal contraceptives modify this risk.

Keywords: birth control pill; cerebral venous sinus thrombosis; cerebral venous thrombosis; hormonal contraceptives; oral contraceptive pill.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for studies included in systematic review and meta-analysis.
Figure 2
Figure 2
Forest plot with pooled odds ratio for relationship between oral contraceptive use and cerebral venous sinus thrombosis (random effects model).
Figure 3
Figure 3
Cumulative meta-analysis using the random effects model.
Figure 4
Figure 4
Assessment of publication bias in meta-analysis using a funnel plot.
See this image and copyright information in PMC

References

    1. Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol (2000) 247:252–8.10.1007/s004150050579 - DOI - PubMed
    1. Saposnik G, Barinagarrementeria F, Brown RD, Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 42:1158–9210.1161/STR.0b013e31820a8364 - DOI - PubMed
    1. Dentali F, Gianni M, Crowther MA, Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood (2006) 108:1129–34.10.1182/blood-2005-12-4795 - DOI - PubMed
    1. McBane RD, II, Tafur A, Wysokinski WE. Acquired and congenital risk factors associated with cerebral venous sinus thrombosis. Thromb Res (2010) 126:81–7.10.1016/j.thromres.2010.04.015 - DOI - PubMed
    1. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood (2006) 107:2766–73.10.1182/blood-2005-09-3578 - DOI - PubMed

LinkOut - more resources